Clinical Trials Browser

Phase 2 × Surveys and Questionnaires × Plasma cell × Clear all

NCT04497961 2025-09-11

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Phase 2 Active not recruiting

Multiple Myeloma

NCT01793051 2021-11-24

Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma

Phase 2 Completed

88 enrolled 6 charts

cyclopia sequence, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00651937 2020-01-14

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Phase 2 Completed

80 enrolled 7 charts

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma